Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
79.32 USD | -1.82% | -4.18% | +2.67% |
May. 22 | Citigroup Downgrades Bio-Techne to Neutral From Buy, With $85 Price Target | MT |
May. 16 | Bio-techne Insider Sold Shares Worth $335,377, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.67% | 12.73B | |
+51.61% | 63.85B | |
-2.45% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.11% | 26.52B | |
-21.51% | 18.69B | |
+22.25% | 12.11B | |
+27.79% | 12.07B | |
-10.05% | 11.19B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- RBC Capital Adjusts Price Target on Bio-Techne to $72 From $71, Sector Perform Rating Kept